Avalo Therapeutics Inc (AVTX)
9.64
-0.75
(-7.22%)
USD |
NASDAQ |
May 16, 16:00
9.64
0.00 (0.00%)
After-Hours: 06:47
Avalo Therapeutics Cash from Financing (Quarterly): 0.001M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.001M |
| September 30, 2023 | 10.70M |
| June 30, 2023 | 0.598M |
| March 31, 2023 | 13.75M |
| December 31, 2022 | 0.082M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -14.78M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.076M |
| September 30, 2021 | 47.64M |
| June 30, 2021 | 21.22M |
| March 31, 2021 | 37.82M |
| December 31, 2020 | 0.20M |
| September 30, 2020 | 0.001M |
| June 30, 2020 | 35.48M |
| March 31, 2020 | 9.098M |
| December 31, 2019 | 0.1355M |
| September 30, 2019 | 3.510M |
| June 30, 2019 | 0.0972M |
| March 31, 2019 | 8.817M |
| Date | Value |
|---|---|
| December 31, 2018 | 6.167M |
| September 30, 2018 | 3.838M |
| June 30, 2018 | 0.0355M |
| March 31, 2018 | 0.3634M |
| December 31, 2017 | 0.0114M |
| September 30, 2017 | -0.6066M |
| June 30, 2017 | 4.211M |
| March 31, 2017 | 0.121M |
| December 31, 2016 | 0.035M |
| September 30, 2016 | 0.3761M |
| June 30, 2016 | -0.9922M |
| March 31, 2016 | -0.8449M |
| December 31, 2015 | 21.40M |
| September 30, 2015 | -1.00M |
| June 30, 2015 | -0.7835M |
| March 31, 2015 | -0.0158M |
| December 31, 2014 | -0.0214M |
| September 30, 2014 | 22.63M |
| June 30, 2014 | 1.325M |
| March 31, 2014 | -0.0747M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-14.78M
Minimum
Jun 2022
47.64M
Maximum
Sep 2021
8.717M
Average
0.20M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Imunon Inc | 0.0302M |
| iBio Inc | 4.005M |
| Kodiak Sciences Inc | -0.124M |
| Petros Pharmaceuticals Inc | -2.373M |
| Ocugen Inc | -0.145M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.766M |
| Free Cash Flow | -30.68M |
| Free Cash Flow Per Share (Quarterly) | -3.45 |
| Free Cash Flow to Equity (Quarterly) | -2.766M |
| Free Cash Flow to Firm (Quarterly) | -2.766M |
| Free Cash Flow Yield | -1.15K% |